Clarkston Capital Partners LLC Boosts Position in Henry Schein, Inc. $HSIC

Key Points

• Clarkston Capital Partners LLC increased its holdings in Henry Schein, Inc. by 0.4%, now owning 1,751,570 shares, which represents 2.4% of its investment portfolio.
• Henry Schein reported $1.10 earnings per share for the last quarter, missing the consensus estimate of $1.19, although revenue increased by 3.3% year-over-year, totaling $3.24 billion.
• Analysts have reduced their price targets on Henry Schein's stock, with a current consensus target of $75.58 and a rating of "Hold" from multiple firms.

Clarkston Capital Partners LLC boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.4% during the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 1,751,570 shares of the company's stock after buying an additional 7,345 shares during the period. Henry Schein makes up about 2.4% of Clarkston Capital Partners LLC's investment portfolio, making the stock its 15th largest position. Clarkston Capital Partners LLC owned 1.44% of Henry Schein worth $119,965,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Farther Finance Advisors LLC raised its stake in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock valued at $186,000 after purchasing an additional 1,898 shares during the period. State of Alaska Department of Revenue raised its stake in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after purchasing an additional 395 shares during the period. Oppenheimer Asset Management Inc. raised its stake in shares of Henry Schein by 5.2% during the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the period. GAMMA Investing LLC raised its stake in shares of Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after purchasing an additional 1,081 shares during the period. Finally, Natixis Advisors LLC raised its stake in shares of Henry Schein by 5.2% during the first quarter. Natixis Advisors LLC now owns 11,508 shares of the company's stock valued at $788,000 after purchasing an additional 572 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Performance

Shares of HSIC opened at $68.64 on Thursday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a market cap of $8.32 billion, a price-to-earnings ratio of 22.14, a price-to-earnings-growth ratio of 2.25 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm has a fifty day moving average of $70.62 and a 200-day moving average of $70.60.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. During the same period last year, the firm posted $1.23 EPS. The business's revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Barrington Research dropped their price target on shares of Henry Schein from $86.00 to $78.00 and set an "outperform" rating for the company in a research note on Wednesday, August 6th. Wells Fargo & Company dropped their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 6th. Stifel Nicolaus restated a "hold" rating and issued a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a research note on Thursday, August 7th. Four analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of "Hold" and a consensus price target of $75.58.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.